Abstract: A connection module capable of integrating electronic control contains: a male connection assembly, a female connection assembly, and a controlling portion. The male connection assembly includes a coupling section, at least one current transmission set, at least one signal transmission set, and at least one engagement portion. The female connection assembly includes a coupling section, at least one current transmission set, at least one signal transmission set, and at least one engagement portion. The controlling portion is connected with the drive mechanism of the male connection assembly to actuate, control and detect the drive mechanism. The male connection assembly is located below the female connection assembly, and the coupling section of the female connection assembly is covered in the coupling section of the male connection assembly. The signal transmission set of the male connection assembly contacts with the signal transmission set of the female connection assembly.

Abstract: A connection module capable of integrating electronic control contains: a male connection assembly, a female connection assembly, and a controlling portion. The male connection assembly includes a coupling section, at least one current transmission set, at least one signal transmission set, and at least one engagement portion. The female connection assembly includes a coupling section, at least one current transmission set, at least one signal transmission set, and at least one engagement portion. The controlling portion is connected with the drive mechanism of the male connection assembly to actuate, control and detect the drive mechanism. The male connection assembly is located below the female connection assembly, and the coupling section of the female connection assembly is covered in the coupling section of the male connection assembly. The signal transmission set of the male connection assembly contacts with the signal transmission set of the female connection assembly.

Abstract: A wire-clamping connector is provided. The wire-clamping connector includes a housing and a contact element. The housing includes a through hole. The contact element is disposed in the housing, and includes a bottom plate structure and an elastic sheet body. The bottom plate structure is disposed opposite to a top wall of the housing, and includes a protruding portion that has a contact surface. A terminal portion of the elastic sheet body is fixed to the top wall, and the elastic sheet body has an acute-angular structure configured to be adjacent to the contact surface. An insertion interval is defined between the acute-angular structure and the contact surface. A wire core of a wire inserted in the through hole enters the insertion interval and is clamped together by the acute-angular structure and the contact surface, and an elastic restoring force is generated by the pressed elastic sheet body.

Abstract: A wire-clamping connector assembly includes a wire-clamping connector and a mating connector. The wire-clamping connector includes a first main body that has a retaining groove, a cover, a conductive cable, and multiple first and second conductive terminals that are embedded in the first main body. The second and the first conductive terminals are opposite to each other and are in a staggered arrangement. Each of the first conductive terminals has one of multiple first upper contact portions, and each of the second conductive terminals has one of multiple second upper contact portions. The conductive cable is disposed on the first main body. The cover is disposed on the conductive cable, and is detachably fixed to the first main body. Each conductor in the conductive cable is in electrical contact with one of the first upper contact portions or one of the second upper contact portions.

Abstract: A wire-clamping connector is provided. The wire-clamping connector includes a housing and a contact element. The housing includes a through hole. The contact element is disposed in the housing, and includes a bottom plate structure and an elastic sheet body. The bottom plate structure is disposed opposite to a top wall of the housing, and includes a protruding portion that has a contact surface. A terminal portion of the elastic sheet body is fixed to the top wall, and the elastic sheet body has an acute-angular structure configured to be adjacent to the contact surface. An insertion interval is defined between the acute-angular structure and the contact surface. A wire core of a wire inserted in the through hole enters the insertion interval and is clamped together by the acute-angular structure and the contact surface, and an elastic restoring force is generated by the pressed elastic sheet body.

Abstract: A socket connector includes an insulated housing and at least one socket terminal. The insulated housing has at least one terminal passage for receiving the at least one socket terminal. The socket terminal has a fixing portion, a conductive clasp extending rearward from the fixing portion along a longitudinal direction, and a pair of contacting arms respectively extending from two opposite sides of the fixing portion. Each contacting arm has an elastic clasp extending from the fixing portion along the longitudinal direction, a port portion connecting to a front end of the elastic clasp, and at least one extending portion extending rearward from an inner side of the port portion. A part of the elastic clasp is bent inward to form a second contacting portion. A part of the port portion and the extending portion form a first contacting section.

Abstract: A socket connector includes an insulated housing and at least one socket terminal. The insulated housing has at least one terminal passage for receiving the at least one socket terminal. The socket terminal has a fixing portion, a conductive clasp extending rearward from the fixing portion along a longitudinal direction, and a pair of contacting arms respectively extending from two opposite sides of the fixing portion. Each contacting arm has an elastic clasp extending from the fixing portion along the longitudinal direction, a port portion connecting to a front end of the elastic clasp, and at least one extending portion extending rearward from an inner side of the port portion. A part of the elastic clasp is bent inward to form a second contacting portion. A part of the port portion and the extending portion form a first contacting section.

Abstract: The present invention relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against influenza virus. The present invention also relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against drug-resistant influenza virus strains. The present invention is further related to a method for treating influenza in a subject, comprising administering to said subject an effective amount of mycophenolate mofetil or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against influenza virus. The present invention also relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against drug-resistant influenza virus strains. The present invention is further related to a method for treating influenza in a subject, comprising administering to said subject an effective amount of mycophenolate mofetil or a pharmaceutically acceptable salt thereof.

Abstract: For the reported resveratrol analogs, the (E)-stilbene core structure is either maintained intact or only slightly modified. We use a different approach and introduced a novel heterocyclic benzothiazolium moiety into the (E)-stilbene core to form a series of novel resveratrol analogs for treating angiogenic- and/or inflammation-related disorders.

Abstract: The present invention provides a pharmaceutical composition and method for treating or preventing influenza virus infection in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of compounds provided in this invention. In addition, the prevent invention provides new compounds for treating or preventing influenza virus infection.

Abstract: Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.

Abstract: Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.

Abstract: Disclosed are 4,5-diamino-3-halo-2-hydroxybenzoic acid derivatives and manufactures thereof. The 4,5-diamino-3-halo-2-hydroxybenzoic acid derivatives are presented by formula (I): wherein R1 group is H, CH3, or C2H5; R2 group is H, or Br; R3 group is CH3, or C3H7; and R4 group is H, or C(?NH)—NH2. 4,5-diamino-3-halo-2-hydroxybenzoic acid derivatives provided here were non-toxic to MDCK cells, particularly compounds 6a, 6b, 6c, 6e, 6f, 7a, 7b and 8 had better anti-H1N1 activity. In the future, these compounds can be used to focus on viral neuraminidases as targets to develop effective anti-influenza drugs.

Abstract: The invention provides a novel medical use of Baicalein, and in particular, a use of baicalein in the preparation of a pharmaceutical composition useful for treating traumatic brain injury. The baicalein pharmaceutical composition in this invention includes a treating effective amount of baicalein and a suitable pharmaceutically acceptable excipient or carrier. The baicalein pharmaceutical composition is applicable for improving the behaviour function deficit in traumatic brain injury, reducing the contusion volume of traumatic brain injury, improving the brain neuronal degeneration in traumatic brain injury, reducing proinflammatory cytokines such as tumor necrosis factor-? (TNF-?), interleukin-1? (IL-1?), interleukin-6 (IL-6) or other relative inflammation factor induced in traumatic brain injury.

Abstract: A watch winder comprising plural watch winder units and a power supply. The plural watch winder units are assembled by connectors in such a manner that the watch winders units are electrically connected to one another, and the power supply is electrically connected to one of the watch winder units to supply power to all the electrically-connected watch winder units. By such arrangements, the respective watch winder units are not required to be provided with one power supply, thus saving the manufacturing cost, satisfying the requirements of environmental protection, and the watch winder units can be assembled as desired.

Abstract: The invention provides a novel medical use of Baicalein, and in particular, a use of baicalein in the preparation of a pharmaceutical composition useful for treating traumatic brain injury. The baicalein pharmaceutical composition in this invention includes a treating effective amount of baicalein and a suitable pharmaceutically acceptable excipient or carrier. The baicalein pharmaceutical composition is applicable for improving the behaviour function deficit in traumatic brain injury, reducing the contusion volume of traumatic brain injury, improving the brain neuronal degeneration in traumatic brain injury, reducing proinflammatory cytokines such as tumor necrosis factor-? (TNF-?), interleukin-1? (IL-1?), interleukin-6 (IL-6) or other relative inflammation factor induced in traumatic brain injury.

Abstract: A watch winder with a sensing switch comprises a housing, a driving member, a rotary watch mount, a light sensor, an adjustable counting device and a main board. The housing is divided by a mid clapboard into a display space and an assembly space. The drive member has a rotary shaft and is disposed in the assembly space, and the rotary shaft is inserted through the mid clapboard into the display space. The rotary watch mount has a fixing portion fixed to the rotary shaft of the drive member and a lightproof portion. The light sensor is disposed on the mid clapboard to sense the lightproof portion. The adjustable counting device is disposed on the mid clapboard and its value is manually adjustable. The main board is disposed in the assembly space of the housing and electrically connected with the drive member, the light sensor and the adjustable counting device.

Abstract: A watch winder comprising plural watch winder units and a power supply. The plural watch winder units are assembled by connectors in such a manner that the watch winders units are electrically connected to one another, and the power supply is electrically connected to one of the watch winder units to supply power to all the electrically-connected watch winder units. By such arrangements, the respective watch winder units are not required to be provided with one power supply, thus saving the manufacturing cost, satisfying the requirements of environmental protection, and the watch winder units can be assembled as desired.

Abstract: A series of isoxazole derivatives and methods of treating immune-mediated diseases by isoxazole derivatives are described.